Senior Director, Global Regulatory Policy at MSD: Leader of regulatory affairs, strategic filing, policy and intelligence with nearly 20 years of experience in the pharmaceutical and healthcare industry. Proven 9 years in managerial role; and 7 years in leadership role including APEC Co-Championship on behalf of the Biotechnology Innovation Organization (BIO). Strong government affairs contacts and networks across markets in APEC.
Sannie initially spent some eleven years’ career at the Singapore’s Health Sciences Authority. As Branch Director of the Singapore Agency, Sannie was responsible for all regulatory decisions pertaining to Chemistry, Manufacturing and Control (CMC). Internationally, she represented Singapore in the WHO prequalification program, the ASEAN Pharmaceutical Products Working Group, and the Australia-Canada-Singapore-Switzerland (ACSS) Consortium for work-sharing initiatives.
In 2014, she accepted a role with F. Hoffmann La-Roche as Asia Pacific Lead in shaping regulatory policy to expedite regulatory convergence to enable patients’ access. As Roche’s Global Lead for reliance and work-sharing, Sannie drives policy development with the APEC Regulatory Harmonization agenda, leading initiatives to track convergence and co-championing the APEC biotherapeutics work areas on behalf of the BIO coalition. In 2018, Sannie was asked to be a Visiting Expert with the Centre of Regulatory Excellence (CoRE) of the Duke-NUS Medical School of Singapore, a role which she continues at MSD.
As a key thought leader, Sannie’s publications include:
- Developing key performance indicators to measure the progress of regional regulatory convergence and cooperation in APEC”; AAPS Open (2018) https://doi.org/10.1186/s41120-018-0024-2
- Measuring progress of regulatory convergence and cooperation among APEC member economies in the context of the COVID-19 pandemic”; Therapeutic Innovation & Regulatory Science (2021) https://doi.org/10.1007/s43441-021-00285-w
- Asia Partnership Conference of Pharmaceutical Associations (APAC) Report on Regulatory Agility Implemented During the COVID‑19 Pandemic: Inspiring Partnerships andRecommendations fortheWay Forward; Therapeutic Innovation & Regulatory Science (2022) https://doi.org/10.1007/s43441-022-00435-8
Sannie holds a bachelor’s degree and a Ph.D. in Chemistry at the University of Hull of the UK and a postdoctoral research fellowship at the University of North Carolina at Chapel Hill of the USA.